Test your basic knowledge |

First Aid Basics

Subjects : health-sciences, first-aid

Instructions:

Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can study here.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.

This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.

1. Aggressive malignant lymphomas (non - Hodgkin's) and Kaposi's sarcoma
ret gene
Where you see Psammoma bodies
DPC gene
AIDS

2. Breast and ovarian cancer 17q tumor suppressor (DNA repair protein)
iron poisoning
BRCA1 gene
Neoplasm associated with xeroderma pigmentosum (albinism)
fat benign tumor

3. Sarcoma
extrinsic apoptosis
malignant mesenchyme tumor (general)
L- myc gene
arsenic target

4. Rhabdomyoma
breast cancer incidence/mortality
smooth muscle benign tumor
beta - hCG
skeletal muscle benign tumor

5. Tumor marker: pancreatic adenocarcinoma
CCl4 target
CA-19-9
p16 gene
TRAP

6. PECAM-1
BRCA1 gene
Leukocyte extravasation: diapedesis
AIDS
WT1 gene

7. ACTH or ACTH- like peptide
CCl4 target
ras gene
beta - hCG
paraneoplastic effects of small cell lung carcinoma

8. Hemangioma
CCl4 target
Red (hemorrhagic) infarcts
ras gene
blood vessels benign tumor

9. Osteosarcoma
Leukocyte extravasation: diapedesis
Resolution of inflammation
bone malignant tumor
AIDS

10. Osteoma
prostate cancer incidence/mortality
immunodeficiency states
aflatoxin target
bone benign tumor

11. Retinoblastoma - osteosarcoma 13q tumor suppressor (blocks G1 to S phase progression)
Rb gene
Neoplasm associated with chronic atrophic gastritis - pernicious anemia - postsurgical gastric remants
Acute inflammatory mediators
Free radical cell damage

12. Liver (centrilobular necrosis - fatty change)
Colon and rectal cancer incidence
CEA
S-100
CCl4 target

13. Malignant lymphoma
TRAP
immunodeficiency states
calcitonin
NF2 gene

14. Vascular: ICAM-1 Leukocyte: LFA-1 (integrin)
blood vessels malignant tumor
Pale infarcts
cigarette smoke target
Leukocyte extravasation: tight binding

15. Leiomyoma
Neoplasm associated with Down Syndrome
Acute inflammatory mediators
smooth muscle benign tumor
malignant epithelial tumor

16. Enzymatic degradation and protein denaturation due to exogenous injury. Inflammatory process where intracellular components extravasate.
Necrosis
acanthosis nigricans (hyperpig and epidermal thickening)
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
erb - B2 gene

17. CML tyrosine kinase (oncogene)
Alk - phos
smooth muscle benign tumor
Free radical eliminators
abl gene

18. Lipoma
TRAP
secondary amyloidosis (reactive systemic)
malignant >1 cell type tumor
fat benign tumor

19. Female 13%/23% and rising Male 16%/33% (mortality has plateaued)
Reversible - plasias
alpha - fetoprotein
calcitonin
lung cancer incidence/mortality

20. Lung - liver - intestine or following reperfusion.
c - kit gene
Red (hemorrhagic) infarcts
immunodeficiency states
prostate cancer incidence/mortality

21. Restoration of normal structure - granulation tissue (vascularized + fibrosis) - abscess (fibrosis + pus) - fistula or scarring (collagen).
Resolution of inflammation
L- myc gene
Napthalene (aniline) dyes target
calcitonin

22. Adenocarcinoma - papillary carcinoma
Neoplasm associated with Down Syndrome
malignant epithelial tumor
p16 gene
Leukocyte extravasation: migration

23. Lung - breast - skin (melanoma) - kidney (renal cell carcinoma) - GI.50% brain tumors are from mets
Primary tumors that met to brain
blood vessels benign tumor
Leukocyte extravasation: migration
abl gene

24. Liver (angiosarcoma)
blood cell malignant tumors
Red (hemorrhagic) infarcts
vinyl chloride target
Alkylating agents target

25. Breast cancer 13q tumor suppressor (DNA repair protein)
BRAC2 gene
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
AIDS
smooth muscle malignant tumor

26. Colorectal cancer (assoc with FAP) 5q tumor suppressor
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)
ulcerative colitis
Leukocyte extravasation: migration
APC gene

27. Wilms' tumor 11p tumor suppressor
acanthosis nigricans (hyperpig and epidermal thickening)
WT1 gene
malignant >1 cell type tumor
fat benign tumor

28. Tumor marker: thyroid medullary carcinoma
calcitonin
CA-125
causes of decreased ESR
malignant mesenchyme tumor (general)

29. Pancreatic cancer (Deleted in Pancreatic Cancer) 18q tumor suppressor
Neoplasm associated with actinic keratosis
NF1 gene
DPC gene
Pale infarcts

30. Tumor marker: Screen for prostate carcinoma. Can also be elevated in BPH and prostatitis.
aflatoxin target
PSA
abl gene
cigarette smoke target

31. Tumor marker: prostate carcinoma marker.
ulcerative colitis
Resolution of inflammation
Prostatic acid phosphatase
Alk - phos

32. Squamous cell carcinoma of the esophagus
Bombesin
arsenic target
Red (hemorrhagic) infarcts
Plummer - Vinson syndrome (atrophic glossitis - esophageal webs - anemia)

33. Mature teratoma in men or malignant teratoma in M/F
malignant >1 cell type tumor
Primary tumors that met to liver
radiation exposure
asbestos target

34. Enzymes: catalase - superoxide dismutase - glutathione peroxidase.Vitamins: ACE Spontaneous decay
AIDS
immunodeficiency states
Free radical eliminators
bone malignant tumor

35. GIST cytokine receptor (oncogene)
fat benign tumor
c - kit gene
erb - B2 gene
Leukocyte extravasation: diapedesis

36. Lung tumor transcription factor (oncogene)
beta - hCG
Autoimmune (Hashimoto's - myasthenia gravis)
Paget's bone disease
L- myc gene

37. Breast - ovarian and gastric carcinomas tyrosine kinase (oncogene)
Necrosis
cigarette smoke target
Second - leading cause of death in the US
erb - B2 gene

38. Leiomyosarcoma
smooth muscle malignant tumor
bone benign tumor
vinyl chloride target
erb - B2 gene

39. Astrocytoma - angiomyolipoma - cardiac rhabdomyoma
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)
Bombesin
Alkylating agents target
dysplastic nevus

40. Visceral malignancy (stomach - lung - breast - uterus)
Barrett's esophagus (chronic GI reflux)
smooth muscle malignant tumor
dysplastic nevus
acanthosis nigricans (hyperpig and epidermal thickening)

41. Lung (mesothelioma and bronchogenic carcinoma)
asbestos target
c - myc gene
smooth muscle malignant tumor
calcitonin

42. ADH
Neoplasm associated with xeroderma pigmentosum (albinism)
paraneoplastic effects of renal cell carcinoma - hemangioblastoma
paraneoplastic effects of thymoma - small cell lung carcinoma
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms

43. Caused by peroxidation of membrane lipids. Causes acute gastric bleeding and chronic metabolic acidosis and scarring.
c - myc gene
iron poisoning
Barrett's esophagus (chronic GI reflux)
BRCA1 gene

44. Blood (leukemia)
Alkylating agents target
Pale infarcts
cirrosis (alcohol - hepB or C)
Primary tumors that met to brain

45. Erythropoietin
Primary tumors that met to liver
paraneoplastic effects of renal cell carcinoma - hemangioblastoma
Alk - phos
Autoimmune (Hashimoto's - myasthenia gravis)

46. 32%/13% male
prostate cancer incidence/mortality
cirrosis (alcohol - hepB or C)
bcl -2 gene
p53 gene

47. Antibodies to presynaptic Ca2+ channels at NM junction
BRAC2 gene
paraneoplastic effects of thymoma - small cell lung carcinoma
causes of decreased ESR
PSA

48. Skin (SqCC) - liver (angiosarcoma)
arsenic target
cirrosis (alcohol - hepB or C)
L- myc gene
malignant mesenchyme tumor (general)

49. Prostate (blastic) - thyroid - testes - breast (lytic and blastic) - lung (lytic) - kidney (breast and prostate are most common)
fat benign tumor
Primary tumors that met to bone
TRAP
Alk - phos

50. Colon>stomach>pancreas>breast>lung (liver and lung are the most common places for mets)
Acute inflammatory mediators
erb - B2 gene
Primary tumors that met to liver
calcitonin